We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Glaucoma Pipeline.
- Abstract
This section offers news briefs related to glaucoma. The U.S. Food and Drug Administration (FDA) approved Healon D, an ophthalmic viscosurgical device from Abbott Medical Optics, to be used to aid glaucoma filtration. An orphan drug destination for Trabomycin, a formulation of mitomycin C was has been received by Mobius Therapeutics for treating glaucoma. GMP Companies Inc. has been approved by the FDA to expand its phase 3 clinical trial of the EyePass Glaucoma Implant.
- Subjects
GLAUCOMA; UNITED States. Food &; Drug Administration; OPHTHALMOLOGY instruments; ABBOTT Medical Optics Inc.; MOBIUS Therapeutics LLC; GMP Cos. Inc.; CLINICAL trials
- Publication
Ocular Surgery News, 2009, Vol 27, Issue 11, p25
- ISSN
8750-3085
- Publication type
Article